Categories: Infectious disease

Founded as a division of the renowned Statens Serum Institut, SSI Diagnostica A/S is now owned by Adelis Equity and is a leading Nordic manufacturing company within the international microbiology market. The product range includes polyclonal antisera for pneumocci, E. coli, Salmonella and streptococci. A broad range of pneumococcal antigens, including serotype specific capsular polysaccharides, is available and bacterial strains including Salmonella, E. coli and pneumococcus are available for use as reference strains.

An increasing number of diagnostic kits are being developed including the Dermatophyte and C. albicans real-time PCR kit for use with nail, hair and skin samples.